Related Experiment Video

Updated: Jun 30, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology

M R Fielden1, T R Zacharewski

  • 1Department of Biochemistry and Molecular Biology, National Food Safety and Toxicology Center, Institute of Environmental Toxicology, Michigan State University, 223 Biochemistry Building, Wilson Road, East Lansing, Michigan 48824, USA.

Toxicological Sciences : an Official Journal of the Society of Toxicology
|February 27, 2001
PubMed

Insights

Toxicogenomics uses gene expression profiling to understand chemical toxicity. This study highlights the limitations and challenges in interpreting this data for accurate toxicity prediction.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Genomics

Background:

  • RNA and protein expression profiling are powerful tools for toxicologists.
  • These technologies promise efficient, high-throughput analysis of chemical and drug effects.
  • Understanding molecular mechanisms of toxicity is crucial for predicting adverse effects.

Purpose of the Study:

  • To address limitations and uncertainties in gene expression profiling for toxicology.
  • To evaluate the expectations of toxicogenomics in mechanistic and predictive toxicology.
  • To discuss challenges in interpreting large-scale gene expression data from in vivo studies.

Main Methods:

  • Review of gene expression profiling technologies.
  • Analysis of data interpretation challenges in toxicogenomics.
  • Discussion of in vivo experimental constraints.

Main Results:

  • Gene expression profiling has limitations impacting its use in toxicology.
  • Interpreting large-scale gene expression data presents significant challenges.
  • Current methodologies require further understanding for reliable toxicity prediction.

Conclusions:

  • Further understanding of gene expression profiling constraints is needed.
  • Addressing data interpretation challenges is key to realizing toxicogenomics potential.
  • Improved methods are necessary for accurate mechanistic and predictive toxicology.

More Related Videos

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...